A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...
The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...
Pharmacotherapy guidelines for type 2 diabetes (T2D) emphasize patient-centered care, but applying this approach effectively in outpatient practice remains challenging. Data-driven treatment ...
T2DM is a major risk factor for CHD. In recent years, machine learning algorithms have demonstrated significant advantages in improving predictive accuracy; however, studies applying these methods for ...
Insulin, a hormone medication used to regulate blood sugar, has long been one of the most important therapies for managing type 2 diabetes. But with the rise of semaglutide (Ozempic) and other ...
In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time ...
W hen first diagnosed with type 2 diabetes, you may have been able to manage blood sugar levels with diet, exercise, and a first-line medication. But as the condition progresses, the body becomes more ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results